Next Article in Journal
Clinical Outcomes and Survival Analysis of Remdesivir as a Treatment Option for Moderate to Severe COVID-19 Patients
Previous Article in Journal
In Silico Screening of Prospective MHC Class I and II Restricted T-Cell Based Epitopes of the Spike Protein of SARS-CoV-2 for Designing of a Peptide Vaccine for COVID-19
 
 
Article

Article Versions Notes

COVID 2022, 2(12), 1748-1757; https://doi.org/10.3390/covid2120125
Action Date Notes Link
article pdf uploaded. 4 December 2022 11:26 CET Version of Record https://www.mdpi.com/2673-8112/2/12/125/pdf-vor
article xml file uploaded 6 December 2022 10:22 CET Original file -
article xml uploaded. 6 December 2022 10:22 CET Update https://www.mdpi.com/2673-8112/2/12/125/xml
article pdf uploaded. 6 December 2022 10:22 CET Updated version of record https://www.mdpi.com/2673-8112/2/12/125/pdf
article html file updated 6 December 2022 10:23 CET Original file -
article html file updated 1 March 2023 02:30 CET Update -
article html file updated 4 March 2023 01:13 CET Update https://www.mdpi.com/2673-8112/2/12/125/html
Back to TopTop